GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Cash Flow from Investing

Aion Therapeutic (XCNQ:AION) Cash Flow from Investing : C$0.00 Mil (TTM As of Jan. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Jan. 2025, Aion Therapeutic spent C$0.00 Mil on purchasing property, plant, equipment. It gained C$0.00 Mil from selling property, plant, and equipment. It spent C$0.00 Mil on purchasing business. It gained C$0.00 Mil from selling business. It spent C$0.00 Mil on purchasing investments. It gained C$0.00 Mil from selling investments. It paid C$0.00Mil for net Intangibles purchase and sale. And it paid C$0.00 Mil for other investing activities. In all, Aion Therapeutic gained C$0.00 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Jan. 2025.


Aion Therapeutic Cash Flow from Investing Historical Data

The historical data trend for Aion Therapeutic's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Cash Flow from Investing Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Cash Flow from Investing
Get a 7-Day Free Trial -0.21 -1.38 - 0.14 -0.29

Aion Therapeutic Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 - - - -

Aion Therapeutic Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Aion Therapeutic's Cash Flow from Investing for the fiscal year that ended in Apr. 2024 is calculated as:

Aion Therapeutic's Cash Flow from Investing for the quarter that ended in Jan. 2025 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aion Therapeutic  (XCNQ:AION) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Aion Therapeutic's purchase of property, plant, equipment for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic spent C$0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Aion Therapeutic's sale of property, plant, equipment for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic gained C$0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Aion Therapeutic's purchase of business for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic spent C$0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Aion Therapeutic's sale of business for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic gained C$0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Aion Therapeutic's purchase of investment for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Aion Therapeutic's sale of investment for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic gained C$0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Aion Therapeutic's net Intangibles purchase and sale for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic paid C$0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Aion Therapeutic's cash from discontinued investing activities for the three months ended in Jan. 2025 was 0.00 Mil. It means Aion Therapeutic paid C$0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Aion Therapeutic's cash from other investing activities for the three months ended in Jan. 2025 was C$0.00 Mil. It means Aion Therapeutic paid C$0.00 Mil for other investing activities.


Aion Therapeutic Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Executives
Ismail Abdul Fattah Director or Senior Officer of 10% Security Holder
Douglas Craig Wilson Director or Senior Officer of 10% Security Holder
John Graham Simmonds Director, Senior Officer

Aion Therapeutic Headlines

No Headlines